Molecule Structure

Scientific Name

Danazol

Description of the Drug

Danazol is a synthetic steroid and pituitary gonadotropin inhibitor used in the treatment of endometriosis and symptomatic treatment of severe pain and tenderness associated with benign fibrocystic breasts.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01406

Brand Name(s)

Danazol, Danocrine

Company Owner(s)

American Therapeutics Inc, Lannett Holdings Inc, Barr Laboratories Inc, Lannett Co Inc, Sanofi Aventis Us Llc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Androgen Receptor SINGLE PROTEIN AGONIST CHEMBL1871
Progesterone receptor SINGLE PROTEIN AGONIST CHEMBL208

Clinical Trial(s)

Unichem Links

Atlas danazol
SureChEMBL SCHEMBL21107
PharmGKB PA164749056
Human Metabolome Database HMDB0002835
DrugBank DB01406
PubChem: Thomson Pharma 14777802 14851335
PubChem 28417
Mcule MCULE-5533294331
LINCS LSM-3073
Nikkaji J24.462G
PDBe QA1
BindingDB 50423541
EPA CompTox Dashboard DTXSID2022880
DrugCentral 779
Brenda 56844
ChemicalBook CB9463336
Guide to Pharmacology 6942
rxnorm DANAZOL
PubChem: Drugs of the Future 123055285
ChEBI 4315
ZINC ZINC000003881958